[ACRX] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
10-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 58.52%
YoY- 46.78%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 511 738 1,368 2,924 386 475 608 -10.93%
PBT -8,956 -8,918 -8,930 -6,602 -15,925 -14,423 -12,731 -20.88%
Tax 858 698 931 4 843 885 1,212 -20.55%
NP -8,956 -8,918 -8,930 -6,606 -15,925 -14,423 -12,731 -20.88%
Tax Rate - - - - - - - -
Total Cost 9,467 9,656 10,298 9,530 16,311 14,898 13,339 -20.41%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -1,752.64 -1,208.40 -652.78 -225.92 -4,125.65 -3,036.42 -2,093.91 -11.17%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -1.58 -1.93 -2.03 -1.64 -3.98 -3.63 -3.20 -37.50%
EPS Diluted -1.58 -1.93 -2.03 -1.64 -3.98 -3.63 -3.20 -37.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.